awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37222790-F80EE624-C906-4A42-8B7D-05D099FE8A8D
Q37222790-F80EE624-C906-4A42-8B7D-05D099FE8A8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37222790-F80EE624-C906-4A42-8B7D-05D099FE8A8D
A phase I dose-escalation study of LY2875358, a bivalent MET antibody, given as monotherapy or in combination with erlotinib or gefitinib in Japanese patients with advanced malignancies.
P2860
Q37222790-F80EE624-C906-4A42-8B7D-05D099FE8A8D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37222790-F80EE624-C906-4A42-8B7D-05D099FE8A8D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f59aa8138433e724fce6d0679934fb2e8c5bd6d6
P2860
Immunohistochemical application of a highly sensitive and specific murine monoclonal antibody recognising the extracellular domain of the human hepatocyte growth factor receptor (MET).